These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 19668445)
21. Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT study. Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M Doc Ophthalmol; 2007 Jan; 114(1):1-7. PubMed ID: 17109155 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of cystoid macular edema with bevacizumab in course of Irvine-Gass syndrome]. Izdebski B; Michalewska Z; Dziegielewski K; Nawrocki J; Odrobina D Klin Oczna; 2013; 115(1):61-4. PubMed ID: 23882744 [TBL] [Abstract][Full Text] [Related]
23. Intravitreal steroids for macular edema in diabetes. Rittiphairoj T; Mir TA; Li T; Virgili G Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392 [TBL] [Abstract][Full Text] [Related]
25. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Saraiva VS; Sallum JM; Farah ME Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465 [TBL] [Abstract][Full Text] [Related]
26. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion. Kim JY; Park SP Korean J Ophthalmol; 2009 Dec; 23(4):259-65. PubMed ID: 20046685 [TBL] [Abstract][Full Text] [Related]
34. Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular edema. Shetty R; Pai SA; Vincent A; Shetty N; Narayana KM; Sinha B; Shetty BK Doc Ophthalmol; 2008 Mar; 116(2):129-35. PubMed ID: 17960440 [TBL] [Abstract][Full Text] [Related]
35. PHARMACOLOGICAL INTRAVITREAL TREATMENT FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION - THREE-MONTH RESULTS. Karadžić J; Kovačević I; Ljikar J; Grgić Z; Devečerski G Med Pregl; 2015; 68(9-10):295-300. PubMed ID: 26727825 [TBL] [Abstract][Full Text] [Related]
36. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]. Jonas JB; Kreissig I; Kamppeter B; Degenring RF Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306 [TBL] [Abstract][Full Text] [Related]
37. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract. Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251 [TBL] [Abstract][Full Text] [Related]
38. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema. Rahimi M; Shahrzad SS; Banifatemi M Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801 [TBL] [Abstract][Full Text] [Related]
39. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic Effects of Combination Therapy and Photobiomodulation Therapy on Retinal Regeneration. Ahrabi B; Omidvari S; Mollazadeh Ghomi S; Ahmady Roozbahany N; Vafaei-Nezhad S; Shirazi Tehrani A; Abbaszadeh HA; Darabi S J Lasers Med Sci; 2022; 13():e36. PubMed ID: 36743147 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]